Borderline COVID-19 PCR Test Result

Official Title

Follow-up of Patients With a Borderline COVID-19 PCR Test Result

Brief Summary

Follow-up of patients with a borderline PCR result. Data of patients that were re-tested within 96 hours after receiving a borderline COVID-19 PCR result are reviewed. This is a retrospective study.

Status

Completed

Conditions

COVID19

Virus

Interventions

Diagnostic Test: SARS-CoV-2 PCR

SARS-CoV-2 PCR of nasopharyngeal lysate.

Eligibility Criteria

Inclusion Criteria:

- Every individual that delivers a nasopharyngeal lysate for SARS-CoV-2 RNA
determination by PCR.

Exclusion Criteria:

- Patients without a previous borderline COVID-19 PCR result within 96 hours are
excluded for the follow-up study.

Eligibility Gender

All

Eligibility Age

Minimum: N/A ~ Maximum: N/A

Countries

Belgium

Locations

Clinical Laboratory Jessa Hospital
Hasselt, Limburg, Belgium

NCT Number

NCT04636294

MeSH Terms

COVID-19

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Jessa Hospital

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA